Pen needles are the devices which are used to deliver the medication (such as insulin or other injectable medications) in combination with injection pens. A pen needle comprises a hollow needle attached to injection pen. They are also available in varied needle lengths and are majorly utilized by diabetes patients.
South America Pen Needles Market size is projected to reach approximately $0.24 billion by the end of 2024 with a CAGR of close to 9.28% from $0.19 billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include rising diabetes prevalence, a comparative advantage over syringes and vials, technological advancements, increasing awareness of the general public, government support in certain countries. However, reusability of pen needles, complications associated with needle use, availability of alternative dosage forms, poor reimbursement policies in underdeveloped and developing countries are thereby hampering the market growth.
South America Pen Needles Market is categorised into therapy which comprises growth hormone, Insulin, and GLP-1. Among them, insulin therapy segment is expected to hold the largest share in
Starting from $2700
Starting from $2700
Starting from $2700
Keep up-to-date with our weekly newsletter, Media Pulse.